Clinvest

Springfield, United States Founded: 1996 • Age: 30 yrs Acquired By Headlands Research
Site Management Organization, specializing in migraine related clinical trials
Request Access

About Clinvest

Clinvest is a company based in Springfield (United States) founded in 1996 was acquired by Headlands Research in May 2023.. The company has 23 employees as of December 31, 2022. Clinvest offers products and services including Migraine Study, Arthritis Study, Diabetes Study, and Vaccine Study. Clinvest operates in a competitive market with competitors including Elligo, Acurian, Velocity Clinical Research, CenExel and Wake Research, among others.

  • Headquarter Springfield, United States
  • Employees 23 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Clinvest Research Llc
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    23

    as on Dec 31, 2022

  • Acquired by
    Headlands Research

    (May 04, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Clinvest

Clinvest offers a comprehensive portfolio of products and services, including Migraine Study, Arthritis Study, Diabetes Study, and Vaccine Study. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Testing new medicines for migraine relief and management.

Evaluating treatments to reduce arthritis pain and improve mobility.

Assessing therapies for diabetes control and weight loss support.

Researching vaccines to prevent infections and enhance immunity.

People of Clinvest
Headcount 10-50
Employee Profiles 7
Employee Profiles
People
Micah Griffin
Physician Assistant
People
Kelsie Starnes
Recruitment Specialist
People
Laura Norman
Recruitment Specialist
People
David True
Medical Director

Unlock access to complete

Funding Insights of Clinvest

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Clinvest

Clinvest has secured backing from 1 investor. Prominent investors backing the company include Headlands Research. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Clinical research services are provided by Headlands Research globally.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Clinvest

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Clinvest

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Clinvest Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Clinvest

Clinvest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elligo, Acurian, Velocity Clinical Research, CenExel and Wake Research, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Patient recruitment and site activation services are provided by Elligo.
domain founded_year HQ Location
Patient enrollment and retention solutions for clinical trials are offered.
domain founded_year HQ Location
Provider of site management and patient recruitment services
domain founded_year HQ Location
Research site management and patient recruitment services are provided.
domain founded_year HQ Location
Clinical site management, patient recruitment, and retention services are provided.
domain founded_year HQ Location
Clinical trial recruitment service company
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Clinvest

Frequently Asked Questions about Clinvest

When was Clinvest founded?

Clinvest was founded in 1996.

Where is Clinvest located?

Clinvest is headquartered in Springfield, United States.

How many employees does Clinvest have?

As of Dec 31, 2022, the latest employee count at Clinvest is 23.

What does Clinvest do?

Clinvest was founded in 1996 in Springfield, United States, and operates as a Site Management Organization in the clinical research sector. FDA Phase II-IV trials are conducted across therapeutic areas including headachemigraine, hypertension, diabetes, osteoarthritis, GI disorders, Alzheimers disease, fibromyalgia, herpes simplex, asthma, low back pain, inflammatory biomarkers, and hyperlipidemia. Over 400 trials have been handled for sponsors and CROs by a team of research coordinators.

Who are the top competitors of Clinvest?

Clinvest's top competitors include Velocity Clinical Research, Elligo and Acurian.

What products or services does Clinvest offer?

Clinvest offers Migraine Study, Arthritis Study, Diabetes Study, and Vaccine Study.

Who are Clinvest's investors?

Clinvest has 1 investor. Key investors include Headlands Research.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available